NeoStem, Inc., is an innovative, publicly traded company positioned to become a leader in the adult stem cell field and to capitalize on the increasing importance adult stem cells are expected to play in the future of regenerative medicine.
Advanced Description :
No additional details have been entered yet. If you would like to moderate the board and provide an advanced description for this stock, please send a Board Moderation Request at top left of board.